CIK: 1180760 - Address: 400 Oyster Point Blvd., Suite 505, So. San Francisco, CA 94080
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/7/07 19:20
5/3/07
AMEX.Titan Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBucalo Louis R MdCADOP,CEOP.m1182.3605010550D
11/3/05 13:33
11/1/05
TTPTitan Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBucalo Louis R MdCADOP,CEOP61.67041500D
10/7/05 19:08
10/6/05
TTPTitan Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBucalo Louis R MdCADOP,Chief P1051.7006214496D
8/18/04 11:12
8/16/04
AMEX.Titan Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBucalo Louis R MdCADOP,CEOP62.20031434D
2/11/04 14:15
2/9/04
TTPTitan Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBucalo Louis R MdCADOP,CEOM.d480.590008223432D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact